Silvaris Heart Institute — Newark, NJ

SilverOak Heart Institute in Newark, New Jersey, is one of the few hospitals in the United States exclusively dedicated to the diagnosis and treatment of cardiovascular disease. Our 220-bed specialty facility brings together the full spectrum of cardiac medicine under one roof — interventional cardiology, structural heart disease, electrophysiology, heart failure management, and cardiothoracic surgery — allowing for a level of integration and coordination impossible in a general hospital setting.

With more than 4,000 cardiac procedures performed annually, our institutional experience translates directly into superior outcomes. Our interventional cardiology team — trained at leading academic centers across the country — manages complex multivessel coronary artery disease, chronic total occlusions, and high-risk percutaneous interventions that many centers decline. Our TAVR (transcatheter aortic valve replacement) program has performed more than 1,800 procedures with in-hospital mortality below 1%.

The electrophysiology program at SilverOak Newark is nationally recognized for its expertise in complex arrhythmia ablation, including ventricular tachycardia ablation in structural heart disease, atrial fibrillation ablation using PulseField technology, and laser lead extraction for infected or malfunctioning devices. Our heart failure team manages advanced decompensated heart failure with temporary mechanical circulatory support and coordinates evaluation for heart transplant through our partner transplant center.

SilverOak Heart Institute Newark holds a three-star rating from the Society of Thoracic Surgeons for isolated coronary artery bypass grafting and a three-star rating for valve procedures — the highest designation available and achieved by fewer than 12% of US cardiac surgery programs. Our outcomes are publicly reported, and we invite patients and referring physicians to review them at our website.